A recent cross-sectional study has highlighted significant gaps in the ability of community pharmacists in Saudi Arabia to support patients with depression, despite being highly accessible healthcare professionals. Conducted by a team led by Fahad Alzahrani from Taibah University, the research was published in BMC Health Services Research and involved surveying 377 licensed pharmacists. The study found a notable disparity between pharmacists' beliefs about their role in depression care and their actual practices.
Read More
The study, which took place between October 2024 and January 2025, assessed pharmacists' current practices, perceptions, and barriers they encounter regarding depression care. With a response rate of 70.7%, this survey presents a comprehensive view of how community pharmacists engage with mental health issues. Results indicated that while pharmacists scored a moderate 77.4% in attitudes towards mental health support, their actual practice score stood at a low 51.0%. This suggests that though they recognize their role in assisting patients with depression, this recognition does not consistently translate into actionable measures.
Most pharmacists reported adhering to medication habits and checking prescriptions, which are tasks that fit easily within their workflow; however, more complex activities such as consulting with physicians or providing educational materials about depression were performed less frequently. This reveals a comfort in mechanical care, but a hesitancy to engage in the deeper communicative aspects of mental health support.
Multiple barriers were identified, including limited access to patient medical histories, inadequate understanding of depression among patients, a lack of privacy in pharmacies, time pressures, and insufficient mental health training. The authors suggest that addressing these structural barriers would be essential to enhance pharmacists' roles in depression care.
Data analysis showed that more professional experience correlated with higher practice scores, implying that skills related to depression care develop over time. Interestingly, pharmacists aged 30 to 39 scored lower than their younger counterparts, potentially due to mid-career pressures. Additionally, those dispensing between 50 and 100 prescriptions daily reported better practice scores, indicating that moderate workloads may allow for more consistent patient interactions.
Concerns were raised regarding the effectiveness of current training programs, as having training in depression care did not significantly correlate with improved practice scores. This suggests that training methods may need to focus more on practical application rather than theoretical knowledge.
The implications of this study extend beyond Saudi Arabia, as the global burden of depression continues to rise. Community pharmacists have a unique opportunity to play pivotal roles in mental health care. The study’s findings propose a reform agenda, emphasizing competency-based training, improved patient record access, private counseling spaces, clearer referral pathways, and enhanced collaboration with healthcare providers.
The authors also stressed the importance of improving public understanding of depression to facilitate better patient interactions and counseling. By addressing these identified gaps, the potential for pharmacists to positively impact mental health care can be significantly enhanced.